A5022440108- Animal Virus Infections Studies
- Gastric Cancer Management and Outcomes
- Congenital Anomalies and Fetal Surgery
- Genomics and Rare Diseases
- Health, Education, and Physical Culture
- Cancer Treatment and Pharmacology
- Neurofibromatosis and Schwannoma Cases
- Health Systems, Economic Evaluations, Quality of Life
- Multiple Myeloma Research and Treatments
- Protein purification and stability
- Lung Cancer Treatments and Mutations
- Genetic Syndromes and Imprinting
- Antibiotic Use and Resistance
- Esophageal Cancer Research and Treatment
- Xenotransplantation and immune response
- Clinical practice guidelines implementation
- Congenital heart defects research
Universidad El Bosque
2024
Pontificia Universidad Javeriana
2021
Hospital Universitario San Ignacio
2021
Universidad Surcolombiana
2010
Immune checkpoint inhibitors (ICIs) are a group of drugs that have improved outcomes for patients with various cancers. Generally considered safe and well tolerated, these occasionally linked to immune-mediated or immune-related adverse events. Among these, autoimmune neurological events rare, displaying varying incidence rates across different studies. Peripheral neuropathy, although one the more common events, is at times underestimated. This case report highlights an adult patient...
Carbapenemase-producing Enterobacterales (CPE) infections have increased in recent years. Colombia has become an endemic country for this group of microorganisms, and the they cause a serious impact terms morbidity mortality. The early identification CPE carriers who are admitted to health care centers as patients is necessary implement adequate isolation infection control measures limit spread type microorganisms hospitals. Furthermore, treating these challenging task due limited...
El cáncer esofagogástrico es un problema de salud pública a nivel mundial y una las principales causas mortalidad principalmente en países ingresos medios bajos con aumento importante lugares estilos vida occidental. A pesar los avances significativos la última década relación biomarcadores tratamiento, persiste cifras supervivencia bajas, lo que indica necesidad estrategias medicina precisión terapia dirigida molecularmente. Esta revisión analiza el panorama actual diagnóstico perfil...